Found 2 clinical trials
Endothelin-1 and Cardiac Allograft Vasculopathy (CAV)
endothelin receptor antagonist (macitentan) prior this catheterization, which will allow us to test how much ET-1 contributes to coronary responsiveness. The findings from this study may provide the
- 0 views
- 25 May, 2022
- 1 location
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension (MACiTEPH)
The purpose of the study is to evaluate the effect of macitentan 75 mg versus placebo on exercise capacity at Week 28 in participants with chronic thromboembolic pulmonary hypertension (CTEPH).
macitentan
- 85 views
- 24 Jul, 2022
- 108 locations